The authors assessed the impact of statin use or non-use in combination with androgen-deprivation therapy among 87,346 men with advanced prostate cancer in the national VA database. On adjusted analysis, statin use was associated with a number of favorable outcomes, including overall survival (HR, 0.66), cancer-specific survival (HR, 0.56), and a longer time before onset of skeletal-related events (HR, 0.64).”
I've been on atorvastatin (40 mg per day) for several years prior to my cancer diagnosis. My PCP put me on it to control my cholesterol - which it has done pretty well. Whether it's done anything about my cancer (I'm also on lupron) is tough to tell, but I don't think it has.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.